POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 27,621 | $184,000 | 0.00% |
| Invesco Ltd. | 132,977 | $886,956 | 0.00% |
| ProShare Advisors LLC | 11,754 | $78,399 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 11,114 | $74,130 | 0.00% |
| Bank of New York Mellon Corp | 332,610 | $2,218,508 | 0.00% |
| LPL Financial LLC | 33,925 | $226,280 | 0.00% |
| J.P. Morgan Private Wealth Advisors LLC | 20,000 | $133,400 | 0.00% |
| Citadel Advisors | 9,000 | $60,030 | 0.00% |
| Citadel Advisors | 900 | $6,003 | 0.00% |
| Mendota Financial Group, LLC | 1 | $7 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 49,900 | $332,833 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 26,183 | $174,641 | 0.00% |
| SIGNATUREFD, LLC | 870 | $5,803 | 0.00% |
| DekaBank Deutsche Girozentrale | 9,092 | $61 | 0.00% |
External links
This page lists POINT BIOPHARMA GLOBAL INC's shareholders in Q3 2023. To view POINT BIOPHARMA GLOBAL INC's shareholder history, click here.